Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Sleep and oligodendrocyte functions.
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes.
Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Endoplasmic reticulum dysfunction in neurological disease.
Mimics and chameleons of optic neuritis.
Clinical designs of recent robot rehabilitation trials.
B-cell enrichment and epstein-barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.
Genetic targeting of microglia.
Gain of glycosylation: A new pathomechanism of myelin protein zero mutations.
Immune Therapy of Multiple Sclerosis - Future Strategies.
Words: Perception, "-Omics" Another Epidemic? Vaccine Optic Neuritis; An Amblyopia Symposium; Strasbismus surgery anesthesia.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
The Challenges for Drug Development: Cytokines, Genes, and Stem Cells.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Inflammation high-field magnetic resonance imaging.
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes.
Natalizumab-induced hepatic injury: A case report and review of literature.
Aquatherapy for neurodegenerative disorders.
Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts.
A case of post-vaccination optic neuritis: coincidence or causative?
MRI correlates of disability in african-americans with multiple sclerosis.
Fingolimod affects gene expression profile associated with LPS-induced memory impairment.
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.
Pages
« first
‹ previous
…
227
228
229
230
231
232
233
234
235
…
next ›
last »